Summary statistics (p values, odds ratios, and minor allele frequencies for all mitochondrial SNPs that were tested) are provided in [S1 Table](#pone.0222284.s001){ref-type="supplementary-material"}.

Background {#sec005}
==========

Breast cancer is the most common cancer in women in the United States. In 2019, it has been estimated there will be 271,270 new cases of breast cancer in the United States \[[@pone.0222284.ref001]\]. Twin studies and familial studies suggested that heredity may account for \~49% of the risk of familial breast cancer \[[@pone.0222284.ref002]--[@pone.0222284.ref004]\]. To date, over 168 breast cancer risk loci have been identified by genome-wide association studies (GWAS) of breast cancer \[[@pone.0222284.ref005]--[@pone.0222284.ref022]\]; yet, inherited variants of germline mitochondrial DNA (mtDNA) have not been fully examined in relation to breast cancer susceptibility. To our knowledge, no study to date has comprehensively examined the relationship between the mitochondrial genome variants and breast cancer risk in multiple ethnic populations.

The mitochondrial genome is a small circular DNA molecule that spans 16.6 kb and has no intronic sequences \[[@pone.0222284.ref023]\]. This genome has become extremely specialized for the synthesis of proteins essential for the oxidative phosphorylation (OXPHOS) system and has retained only a small number of genes over the course of evolution \[[@pone.0222284.ref024]\]. Thirty-seven genes are encoded by the mitochondrial genome, comprising 13 essential polypeptides of the oxidation phosphorylation system and the RNA machinery necessary for their translation (2 ribosomal RNAs and 22 transfer RNAs)\[[@pone.0222284.ref024]\]. The remaining proteins of the mitochondrial electron transport chain and those needed for mtDNA maintenance are encoded by nuclear DNA and synthesized by cytoplasmic ribosomes \[[@pone.0222284.ref024]\].

The primary function of the mitochondrion is the production of the energy molecule, adenosine triphosphate (ATP), through the metabolic pathway of OXPHOS. In addition, the mitochondrion also serves as the major source of reactive oxygen species (ROS). ROS are involved in many cellular processes such as apoptosis, inflammation and oxidative stress. They are generally considered as toxic agents that contribute to aging, a wide variety of degenerative diseases, and cancer \[[@pone.0222284.ref025], [@pone.0222284.ref026]\]. Moreover, the mitochondrion itself is a sensitive target for the damaging effects of ROS. In particular, mtDNA is highly susceptible to oxidative damage due to its lack of protective histones and its close proximity to the electron transport chain, leading to instability of the mitochondrial genome in cancer cells \[[@pone.0222284.ref027]--[@pone.0222284.ref029]\]. In addition, less efficient DNA repair processes have been reported for mtDNA in comparison to nuclear DNA \[[@pone.0222284.ref030]--[@pone.0222284.ref032]\].

Variations in mtDNA have the potential to alter mitochondrial function and lead to increased oxidative stress and breast cancer risk \[[@pone.0222284.ref033]--[@pone.0222284.ref039]\]. Canter et al. tested the association between mtDNA G10398A and breast cancer risk firstly in 48 African American breast cancer cases and 54 African American controls followed by a validation study of 654 breast cancer cases and 605 controls \[[@pone.0222284.ref033]\], and reported an association in African-Americans (OR = 1.60, p value = 0.013), yet no association in Whites (OR = 1.03, p value = 0.81). Setiawan et al. found no association with mtDNA, G10398A and breast cancer risk \[[@pone.0222284.ref040]\] in a study of 1,456 African American breast cancer cases and 978 African American controls. Similarly, no association with mtDNA G10398A and breast cancer risk was found in a study of 716 cases and 724 controls in a South Indian population \[[@pone.0222284.ref035]\]. Recently, Blein et al. conducted a large scale study of 11,421 breast cancer affected and 10,793 unaffected BRCA1/2 mutation carriers of European ancestry, and identified an inverse association between mtDNA haplogroup T1a1 and breast cancer risk (Hazard Ratio = 0.62, 95% Confidence Interval = 0.40--0.95; P = 0.03) \[[@pone.0222284.ref037]\]. Other small studies have reported other candidate polymorphisms (G9055A, T16519 or G6267A) to be associated with breast cancer risk among European ancestry women \[[@pone.0222284.ref041], [@pone.0222284.ref042]\]. These inconsistent findings may be due to differences in study design, study populations, and small sample sizes with limited statistical power.

To investigate the association between mitochondrial genetic variation and breast cancer risk across multiple racial/ethnic groups, we tested 314 mtSNPs among 5,983 subjects (2,723 breast cancer cases and 3,260 controls) in the Multiethnic Cohort Study (MEC).

Methods {#sec006}
=======

Study subjects {#sec007}
--------------

Our study included 2,723 incident breast cancer cases and 3,260 controls nested within the MEC, a large population-based cohort of more than 215,000 subjects comprised of African Americans, European Americans, Japanese Americans, Latinos, and Native Hawaiians, who were recruited from 1993 through 1996 at the ages of 45 and 75 years \[[@pone.0222284.ref043]\]. Blood samples were collected from incident breast and colorectal cancer cases after their diagnosis, as well as a random sample of cohort members to serve as controls from 1996 through 2001, and prospectively from all willing surviving participants from 2002 through 2007. Incident breast cancer cases were identified through cohort linkage to population-based cancer Surveillance, Epidemiology and End Results (SEER) registries in California and Hawaii up to December 9, 2010. Control subjects were women selected to not have breast cancer before cohort entry or during follow-up as of December 9, 2010 and served as matched controls on age (5-year age groups) and race/ethnicity for our nested breast and colorectal cancer studies. This study was approved by the institutional review board at the University of Hawaii and University of Southern California. Written informed consent was obtained from all subjects.

mtSNPs genotyping {#sec008}
-----------------

Mitochondrial SNPs were genotyped using the Sequenom platform (n = 186 mtSNPs) \[[@pone.0222284.ref044]\] and the Illumina Exome array \[[@pone.0222284.ref045]\] (n = 240 mtSNPs). The 2,723 cases and 3,260 controls were shared between the two genotyping platforms with an average call rate of 99.83%. Forty mtSNPs were common in both genotyping platforms with a concordance rate of 99.3%. Of the 386 unique mtSNPs across the two genotyping platforms, we excluded 72 mtSNPs with MAF\<0.1% among the overall sample, resulting in 314 mtSNPs that were distributed across 13 mtDNA genes, comprising four complexes of the OXPHOS pathway, and the tRNA and rRNA subunits (19 mtSNPs per kb).

Statistical analysis {#sec009}
--------------------

For the mitochondrial genome, pathway, complex, gene-based analysis, we used the sequence kernel association test (SKAT) \[[@pone.0222284.ref046], [@pone.0222284.ref047]\]. The SKAT_commonrare test is an omnibus procedure allowing for both rare and common variants to contribute to the overall test statistic. For this test, the minor allele frequency of threshold for rare variants was determined by sample size ($T = \frac{1}{\sqrt{2n}}$) \[[@pone.0222284.ref047]\] (0.1%\< MAF\<1% for African, Asian, European, Latino ancestry groups; 1%\<MAF\<5% for Native Hawaiians). All analyses were adjusted for age, self-reported maternal race/ethnicity, and the first five principal components of genetic ancestry. The principal components of genetic ancestry were estimated from a panel of 128 ancestry informative markers \[[@pone.0222284.ref048], [@pone.0222284.ref049]\]. For single mtSNP and haplogroup analyses, we conducted unconditional logistic regression, adjusting for the same covariates listed above. Haplogroups were estimated using the HaploGrep software ([http://www.haplogrep.uibk.ac.at](http://www.haplogrep.uibk.ac.at/)) and based on Phylotree build 16 \[[@pone.0222284.ref050], [@pone.0222284.ref051]\]. Additional adjustment for family history of breast cancer, age at menarche, age at first birth, age at menopause, parity, hormone replacement therapy (HRT) use, body mass index (BMI), alcohol, and smoking did not notably alter the results. Thus, these covariates were not included in our final multivariate models. Stratified analyses were conducted by self-reported maternal race/ethnicity. All statistical tests presented are two-sided. A false discovery rate (FDR) was used to account for multiple hypothesis testing for the mitochondrial genome, OXPHOS pathway, complexes, genes, and haplogroup for the five racial/ethnic groups and overall. A false discovery rate q value \[[@pone.0222284.ref052]\] of 0.20 was used as a threshold to determine statistical significance, which is equivalent to a nominal p value of 6.7x10^-4^ (0.2/300) for \~300 mtSNPs tested and p-value = 0.01 (0.2/20) for the \~20 mitochondrial gene-based tests.

Results {#sec010}
=======

Study characteristics of the 5,983 study subjects (2,723 breast cancer cases; 3,260 controls) are presented in [Table 1](#pone.0222284.t001){ref-type="table"}. The distribution of maternal race/ethnicity was 23.3% African Americans, 28.7% Asian Americans, 25.5% European Americans, 16.4% Latinos and 6.1% Native Hawaiians. Breast cancer cases were of younger age at menarche, older age at menopause, had fewer children, higher BMI, had higher use of hormone replacement therapy (HRT), more likely to have a family history of breast cancer, consume alcohol, and have a history of diabetes than controls. Approximately 72.2% of breast cancer cases had localized disease and 72.1% were hormone receptor positive. [S1 Table](#pone.0222284.s001){ref-type="supplementary-material"} shows the distribution of study characteristics by maternal race/ethnicity.

10.1371/journal.pone.0222284.t001

###### Study characteristics of 2,723 breast cancer cases and 3,260 controls in the MEC.

![](pone.0222284.t001){#pone.0222284.t001g}

  Characteristics                                                     Categories                                      Cases (n = 2,723)   Controls (n = 3,260)
  ------------------------------------------------------------------- ----------------------------------------------- ------------------- ----------------------
  Age[†](#t001fn001){ref-type="table-fn"}, mean (SD)                                                                  66.10 (0.17)        66.25 (0.16)
  Maternal race/ethncity, n(%)[††](#t001fn002){ref-type="table-fn"}   African Americans                               463 (17.07%)        923 (28.43%)
                                                                      Asian Americans                                 808 (29.78%)        900 (27.73%)
                                                                      Latinos                                         512 (18.87%)        464 (14.29%)
                                                                      European Americans                              745 (27.46%)        769 (23.69%)
                                                                      Native Hawaiians                                179 (6.6%)          186 (5.73%)
  Age at Menarche                                                     Younger than 13yrs                              1437 (53.62%)       1590 (49.3%)
                                                                      Age between 13\~14yrs                           960 (35.82%)        1267 (39.29%)
                                                                      Age over than 15yrs                             283 (10.56%)        368 (11.41%)
  Age at first birth                                                  Nulliparis                                      408 (15.37%)        379 (11.87%)
                                                                      Younger than 20yrs                              608 (22.9%)         873 (27.34%)
                                                                      Age between 21\~30yrs                           1420 (53.48%)       1698 (53.18%)
                                                                      Age over than 30yrs                             219 (8.25%)         243 (7.61%)
  Age at menopause[††](#t001fn002){ref-type="table-fn"}               Pre-menopausal                                  162 (11.83%)        203 (13.22%)
                                                                      natural menopause at age \<45                   397 (29%)           483 (31.45%)
                                                                      natural menopause at age 45--49                 621 (45.36%)        674 (43.88%)
                                                                      natural menopause at age 50--54                 189 (13.81%)        176 (11.46%)
  Parity                                                              Nulliparous                                     417 (15.42%)        396 (12.2%)
                                                                      1 Child                                         312 (11.54%)        354 (10.91%)
                                                                      2\~3 children                                   1244 (46.01%)       1533 (47.23%)
                                                                      More than 4 children                            731 (27.03%)        963 (29.67%)
  HRT use                                                             Never used HRT                                  1114 (41.8%)        1505 (47.1%)
                                                                      Ever used estrogen or progestin                 463 (17.37%)        602 (18.84%)
                                                                      Current use estrogen or progestin               1088 (40.83%)       1088 (34.05%)
  BMI, n (%)                                                          \<25 kg/m2                                      946 (39.66%)        1213 (42.35%)
                                                                      \> = 25 kg/m2                                   1439 (60.34%)       1651 (57.65%)
  Family history of breast cancer, n (%)                              Yes                                             447 (16.042%)       382 (11.72%)
  Alcohol, g/day, mean (SD)                                           Yes                                             5.58 (16.35)        4.51 (14.55)
  Smoking, pack/year, mean (SD)                                       Yes                                             7.35 (12.69)        6.85 (12.22)
  History of Diabetes, n (%)                                          Yes                                             317 (12.44%)        319 (10.38%)
  stage (%)[\*](#t001fn004){ref-type="table-fn"}                      Localized                                       1951 (72.15%)       \--
                                                                      Advanced[\*](#t001fn004){ref-type="table-fn"}   726 (26.78%)        \--
  HR status[‡](#t001fn003){ref-type="table-fn"}                       Positive                                        1953 (72.07%)       \--

†Age of diagnosis for cases and age at blood draw for controls

††Due to missing value, the total doesn\'t add up to 100%.

‡Either estrogen Receptor (ER) or progesterone Receptor (PR) status is positive.

\*Including regional and distant disease.

Mitochondrial genome, pathway, and gene analysis {#sec011}
------------------------------------------------

No statistically significant associations were observed with the mitochondrial genomes, pathways, or genes in all groups combined and among African Americans, Asian Americans, Latinos, and Native Hawaiians ([Table 2](#pone.0222284.t002){ref-type="table"}). Yet, in European Americans, a global test of the mitochondrial genome (collective set of 261 mtSNPs with MAF \>0.1%) revealed an association with breast cancer risk (P = 0.017, q = 0.102; [Table 2](#pone.0222284.t002){ref-type="table"}). In addition, two mtDNA genes, NADH dehydrogenase 2 (*MT-ND2*; P = 0.004, q = 0.19) and cytochrome c oxidase II (*MT-CO2*; P = 0.001, q = 0.095) were associated with breast cancer risk in European Americans ([Table 2](#pone.0222284.t002){ref-type="table"}).

10.1371/journal.pone.0222284.t002

###### Association between mitochondrial genome, pathways, genes and breast cancer risk by maternal race/ethnicity and overall in the MEC.

![](pone.0222284.t002){#pone.0222284.t002g}

  Maternal Race/Ethnicity   Mitochondrial genome   Mitochondrial Oxidative phosphoralation pathway   Mitochondrial complex                 Mitochondrial gene                                                                                   
  ------------------------- ---------------------- ------------------------------------------------- ----------------------- ----- ------- -------------------- ------------- ----- ------- ------- -------------- -------- ------- ----------- -----------
  **African Americans**     290                    0.752                                             0.902                   208   0.743   0.968                Complex I     120   0.613   0.993   *MT-ND1*       17       6       0.066       0.523
                                                                                                                                                                                                    *MT-ND2*       21       7       0.745       1.000
                                                                                                                                                                                                    *MT-ND3*       8        5       0.863       1.000
                                                                                                                                                                                                    *MT-ND4*       20       9       0.344       1.000
                                                                                                                                                                                                    *MT-ND4L*      4        2       0.608       1.000
                                                                                                                                                                                                    *MT-ND5*       41       19      0.970       1.000
                                                                                                                                                                                                    *MT-ND6*       9        4       0.703       1.000
                                                                                                                                                                Complex III   37    0.545   0.993   *MT-CYB*       37       14      0.545       1.000
                                                                                                                                                                Complex IV    37    0.988   0.993   *MT-CO1*       20       11      0.978       1.000
                                                                                                                                                                                                    *MT-CO2*       5        5       1.000       1.000
                                                                                                                                                                                                    *MT-CO3*       12       7       0.726       1.000
                                                                                                                                                                Complex V     14    0.542   0.993   *MT-ATP6*      10       4       0.407       1.000
                                                                                                                                                                                                    *MT-ATP8*      4        1       0.791       1.000
                                                                                                                                                                                                    *MT-DLOOP*     6        3       0.544       1.000
                                                                                                                                                                                                    rRNA           46       22      0.770       1.000
                                                                                                                                                                                                    tRNA           30       10      0.751       1.000
  **Asian Americans**       193                    0.972                                             0.972                   146   0.923   0.968                Complex I     79    0.653   0.993   *MT-ND1*       12       3       0.203       0.891
                                                                                                                                                                                                    *MT-ND2*       14       14      0.459       1.000
                                                                                                                                                                                                    *MT-ND3*       5        3       0.235       0.891
                                                                                                                                                                                                    *MT-ND4*       18       3       0.461       1.000
                                                                                                                                                                                                    *MT-ND4L*      2        1       0.843       1.000
                                                                                                                                                                                                    *MT-ND5*       23       10      0.944       1.000
                                                                                                                                                                                                    *MT-ND6*       5        2       0.904       1.000
                                                                                                                                                                Complex III   31    0.974   0.993   *MT-CYB*       31       13      0.954       1.000
                                                                                                                                                                Complex IV    22    0.993   0.993   *MT-CO1*       9        2       0.980       1.000
                                                                                                                                                                                                    *MT-CO2*       4        2       0.882       1.000
                                                                                                                                                                                                    *MT-CO3*       9        4       0.599       1.000
                                                                                                                                                                Complex V     14    0.320   0.993   *MT-ATP6*      11       5       0.272       0.891
                                                                                                                                                                                                    *MT-ATP8*      3        1       0.974       1.000
                                                                                                                                                                                                    MT-DLOOP       5        2       0.968       1.000
                                                                                                                                                                                                    rRNA           24       13      0.945       1.000
                                                                                                                                                                                                    tRNA           18       3       0.888       1.000
  **Latinos**               248                    0.384                                             0.816                   185   0.457   0.968                Complex I     107   0.489   0.993   *MT-ND1*       15       4       0.758       1.000
                                                                                                                                                                                                    *MT-ND2*       16       6       0.336       1.000
                                                                                                                                                                                                    *MT-ND3*       7        3       0.756       1.000
                                                                                                                                                                                                    *MT-ND4*       20       7       0.257       0.891
                                                                                                                                                                                                    *MT-ND4L*      4        0       0.080       0.585
                                                                                                                                                                                                    *MT-ND5*       36       6       0.588       1.000
                                                                                                                                                                                                    *MT-ND6*       9        3       0.846       1.000
                                                                                                                                                                Complex III   32    0.690   0.993   *MT-CYB*       32       5       0.684       1.000
                                                                                                                                                                Complex IV    32    0.413   0.993   *MT-CO1*       17       4       0.447       1.000
                                                                                                                                                                                                    *MT-CO2*       5        1       0.204       0.891
                                                                                                                                                                                                    *MT-CO3*       10       3       0.562       1.000
                                                                                                                                                                Complex V     14    0.170   0.714   *MT-ATP6*      9        2       0.155       0.775
                                                                                                                                                                                                    *MT-ATP8*      5        1       0.239       0.891
                                                                                                                                                                                                    MT-DLOOP       5        2       0.855       1.000
                                                                                                                                                                                                    rRNA           41       11      0.112       0.709
                                                                                                                                                                                                    tRNA           17       2       0.917       1.000
  **European Americans**    **261**                **0.017**                                         **0.102**               189   0.015   0.252                Complex I     105   0.022   0.420   *MT-ND1*       14       3       0.605       1.000
                                                                                                                                                                                                    ***MT-ND2***   **17**   **5**   **0.004**   **0.190**
                                                                                                                                                                                                    *MT-ND3*       7        2       0.042       0.496
                                                                                                                                                                                                    *MT-ND4*       18       8       0.349       1.000
                                                                                                                                                                                                    *MT-ND4L*      3        1       0.222       0.891
                                                                                                                                                                                                    *MT-ND5*       36       8       0.031       0.496
                                                                                                                                                                                                    *MT-ND6*       10       1       0.036       0.496
                                                                                                                                                                Complex III   35    0.047   0.494   *MT-CYB*       35       9       0.047       0.496
                                                                                                                                                                Complex IV    34    0.030   0.420   *MT-CO1*       18       2       0.297       0.941
                                                                                                                                                                                                    ***MT-CO2***   **5**    **2**   **0.001**   **0.095**
                                                                                                                                                                                                    *MT-CO3*       11       3       0.363       1.000
                                                                                                                                                                Complex V     15    0.069   0.580   *MT-ATP6*      13       2       0.137       0.766
                                                                                                                                                                                                    *MT-ATP8*      2        0       0.011       0.348
                                                                                                                                                                                                    MT-DLOOP       6        3       0.259       0.891
                                                                                                                                                                                                    rRNA           44       11      0.154       0.775
                                                                                                                                                                                                    tRNA           22       8       0.021       0.496
  **Native Hawaiians**      75                     0.544                                             0.816                   57    0.785   0.968                Complex I     32    0.859   0.993   *MT-ND1*       4        1       0.563       1.000
                                                                                                                                                                                                    *MT-ND2*       6        2       0.588       1.000
                                                                                                                                                                                                    *MT-ND3*       4        1       0.768       1.000
                                                                                                                                                                                                    *MT-ND4*       6        0       0.520       1.000
                                                                                                                                                                                                    *MT-ND5*       11       1       1.000       1.000
                                                                                                                                                                                                    *MT-ND6*       1        0       0.058       0.501
                                                                                                                                                                Complex III   10    0.504   0.993   *MT-CYB*       10       1       0.510       1.000
                                                                                                                                                                Complex IV    10    0.905   0.993   *MT-CO1*       5        2       0.709       1.000
                                                                                                                                                                                                    MT-CO2         2        0       0.858       1.000
                                                                                                                                                                                                    *MT-CO3*       3        0       0.638       1.000
                                                                                                                                                                Complex V     5     0.492   0.993   *MT-ATP6*      4        1       0.725       1.000
                                                                                                                                                                                                    *MT-ATP8*      1        0       0.058       0.501
                                                                                                                                                                                                    MT-DLOOP       1        0       0.648       1.000
                                                                                                                                                                                                    rRNA           10       3       0.102       0.692
                                                                                                                                                                                                    tRNA           7        1       0.459       1.000
  **Overall**               314                    0.525                                             0.816                   227   0.537   0.968                Complex I     127   0.380   0.993   *MT-ND1*       17       10      0.590       1.000
                                                                                                                                                                                                    *MT-ND2*       22       19      0.039       0.496
                                                                                                                                                                                                    *MT-ND3*       9        8       0.270       0.891
                                                                                                                                                                                                    *MT-ND4*       23       16      0.515       1.000
                                                                                                                                                                                                    *MT-ND4L*      4        4       0.765       1.000
                                                                                                                                                                                                    *MT-ND5*       43       27      0.741       1.000
                                                                                                                                                                                                    *MT-ND6*       9        8       0.576       1.000
                                                                                                                                                                Complex III   44    0.821   0.993   *MT-CYB*       44       25      0.821       1.000
                                                                                                                                                                Complex IV    38    0.434   0.993   *MT-CO1*       20       15      0.636       1.000
                                                                                                                                                                                                    *MT-CO2*       5        5       0.245       0.891
                                                                                                                                                                                                    *MT-CO3*       13       9       0.465       1.000
                                                                                                                                                                Complex V     18    0.797   0.993   *MT-ATP6*      15       9       0.766       1.000
                                                                                                                                                                                                    *MT-ATP8*      3        2       0.595       1.000
                                                                                                                                                                                                    MT-DLOOP       6        4       0.788       1.000
                                                                                                                                                                                                    rRNA           52       38      0.715       1.000
                                                                                                                                                                                                    tRNA           29       13      0.136       0.766

\*Pathway and gene-based analysis were adjusted for age, sex, maternal race/ethnicity (all groups combined), and genetic ancestry.

^\#^ Treshold of MAF to differenciate common and rare mtSNPs 0.1%\<MAF\<1% in each maternal ethnicities exept in Hawaiian 1%\<MAF\<5%.

MtSNP and haplogroup associations {#sec012}
---------------------------------

Overall among all groups combined, 11 of 314 mtSNPs were associated with breast cancer risk at P\<0.05 ([S2 Table](#pone.0222284.s002){ref-type="supplementary-material"}) with the most significant association seen with tRNA mtSNP (mt15904; P = 0.005) that did not reach our FDR criterion of statistical significance. In maternal race/ethnicity stratified analyses of mtSNPs (MAF\>0.01), 5 of 280 mtSNPs, 4 of 189 mtSNPs, 13 of 249 mtSNPs, and 7 of 240 mtSNPs were associated with breast cancer risk at P\<0.05 in African Americans, Asian Americans, European Americans, and Latinos, respectively and did not reach our statistical significance threshold ([S2 Table](#pone.0222284.s002){ref-type="supplementary-material"} and [Fig 1](#pone.0222284.g001){ref-type="fig"}). No mtSNP associations were observed in Native Hawaiians. Haplogroup associations and frequencies by case/control status for each maternal racial/ethnic group are presented in [S3 Table](#pone.0222284.s003){ref-type="supplementary-material"}. No haplogroup associations were seen across the five racial/ethnic groups.

![Mitochondrial solar plot for European Americans.\
The three white circles from the outer to inner circles correspond to the P value of 10^−3^, 10^−2^ and 10^−1^. The teal circle represents a p-value of 0.05. Each dot represents the mtSNP association with breast cancer color coded by mitochondrial gene.](pone.0222284.g001){#pone.0222284.g001}

Discussion {#sec013}
==========

In this study, we comprehensively examined the association between the mitochondrial genetic variation and breast cancer risk in five racial/ethnic groups. To our knowledge, this is the first study to examine the collective mitochondrial genome, pathways, genes, and mtSNPs for their associations with breast cancer risk in a multiethnic population. No mitochondrial genome associations were observed in African Americans, Asian Americans, Latinos, and Native Hawaiians. Yet, an association between mitochondrial genetic variation and breast cancer risk was observed among European Americans.

In European Americans, the most significant association was seen with the *MT-CO2* gene that is part of the respiratory Complex IV ([cytochrome c oxidase](https://en.wikipedia.org/wiki/Cytochrome_c_oxidase)). In vitro studies have reported over expression of *MT-CO2* in human breast cancer epithelial cells and reduced breast tumor growth with treatment of a *MT-CO2* inhibitor \[[@pone.0222284.ref053], [@pone.0222284.ref054]\]. The other significant association was observed with the *MT-ND2* gene, a member of the OXPHOS pathway that encodes for the subunit of NADH. It is reasonable to hypothesize that mtDNA coding variants in *MT-CO2* and *MT-ND2* genes may have cis-acting effects on the expression of these genes that may be distinct to European ancestry populations as a recent study reported specific SNP-gene expression patterns between African and Caucasian populations \[[@pone.0222284.ref055]\]. In addition, nuclear DNA encoded transcription factors have been shown to bind to coding regions in mtDNA to regulate gene expression \[[@pone.0222284.ref056]--[@pone.0222284.ref058]\].

In a large study of *BRCA1/2* mutation carriers in the CIMBA consortium (11,421 cases/ 10,793 controls), haplogroup T1a1 was inversely associated with breast cancer risk (Hazard Ratio = 0.62; P = 0.03) among *BRCA1* carriers of European ancestry \[[@pone.0222284.ref037]\]. Our study did not observe an association between haplogroup T1a1 and breast cancer risk, which may be attributed to differences in our population-based study population in comparison to *BRCA1/2* carriers and differences in study power. A small study of European women (164 breast cancer cases/ 164 controls) reported haplogroup H to be associated with breast cancer risk (OR  =  2.0; 95% CI: 1.1--3.5) \[[@pone.0222284.ref036]\]. In our study, haplogroup HV was not statistically significantly associated with breast cancer risk in European Americans (OR = 1.59, 95%CI: 0.99--2.57, P = 0.059) ([S3 Table](#pone.0222284.s003){ref-type="supplementary-material"}).

Two small case-control studies reported mtDNA G13708A to be associated with breast cancer risk in African American and South Indian women, but three other studies \[[@pone.0222284.ref034], [@pone.0222284.ref035], [@pone.0222284.ref040]\] failed to confirm an association. We found no association with this specific polymorphism and the *MT-ND5* gene.

Our study has several strengths. Given the wide spectrum of rare, low-frequency, and common genetic variants in the mitochondrial genome, the use of the SKAT common/rare approach to collectively test multiple risk alleles has improved statistical power to detect modest effects than single SNP tests and overcomes the limitation of previous methods that upweight rare variants \[[@pone.0222284.ref047], [@pone.0222284.ref059]\]. Using this approach, we were able to capture the role of multiple mtDNA genes involved in breast cancer risk. In addition, we expect bias due to heteroplasmy to be unlikely, as prior work has reported heteroplasmy in blood DNA to be quite small \[[@pone.0222284.ref060]\]. We do recognize the limitation of the modest sample size to detect weak genetic effects for certain subgroups such as Native Hawaiians.

Conclusion {#sec014}
==========

In summary, our findings suggest that collectively multiple mtDNA variants may play a role in breast cancer risk in European Americans. The findings of association between the mitochondrial OXPHOS pathway and multiple mitochondrial complexes and genes warrant replication in other European population. Further studies in larger populations should evaluate both the mitochondrial genome and nuclear encoded mitochondrial genomes to fully examine their contribution to breast cancer risk. A recent study examined the association between nuclear genetic variation and mitochondrial transcript abundance based on genotyping data and RNA sequencing data for 36 tissues/cell types, and found 64 nuclear loci associated with expression level of 14 genes encoded by the mitochondrial genome that included missense variants of genes involved in mitochondrial function \[[@pone.0222284.ref061]\].
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GWAS

:   genome-wide association study

OXPHOS

:   oxidative phosphorylation

mtSNPs

:   mitochondrial SNPs

mtDNA

:   mitochondrial DNA

ATP

:   adenosine triphosphate

ROS

:   reactive oxygen species

MEC

:   Multiethnic Cohort Study

SKAT

:   sequence kernel association test

HRT

:   hormone replacement therapy

BMI

:   body mass index

FDR

:   false discovery rate

MT-ND2

:   Mitochondrial NADH dehydrogenase 2

MT-CO2

:   Mitochondrial cytochrome c oxidase II
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